InSilico Medicine (HKG:3696) Chairman and CEO Aleksandrs Zavoronkovs has increased his stake in the company by purchasing an additional 113,500 shares, according to a Monday bourse filing.
The biotech company said Zavoronkovs purchased the shares on the open market between Sept. 4 and Sept. 7 using personal funds.
Following the purchase, Zavoronkovs now owns 46,757,000 shares, or about 8.02% of outstanding shares.
Shui On Land (HKG:0272) said a company in which it holds a 19.8% stake agreed to sell a property in China to Chongqing Shengjuge Real Estate Agency for 201 million yuan.Chongqing Shui On Tiandi Real Estate Development expects the sale of the commercial site with a gross floor area of 31,287 square meters to support its resource allocation and cash flow, according to a Tuesday filing in Hong Kong.
Lisi Group (HKG:0526) unit Ningbo Lisi Household Products renewed the lease of a factory space and office property in China ahead of its Sept. 30 expiry.The new lease agreement signed with lessor Da Mei (Ningbo) New Materials will be effective for three years starting Oct. 1, 2026, and ending Sept. 30, 2029.
Hunlicar Group (HKG:3638) named CEO Chan Wing Sum as its acting chairman effective Friday, according to a same-day bourse filing.